Innate Immune Discrimination Failure In α-Synuclein Pathology: A Mimicry Framework
CWSF · 2026 Disease & Illness Bronze Medal
Overview
Neurodegenerative diseases such as Parkinson's are predominantly framed as problems of protein accumulation and downstream clearance, implicitly assuming that pathogenic conformations are sufficiently distinguishable for targeted intervention. Yet current therapies remain largely symptomatic, lacking capacity to directly engage the underlying protein pathology. I propose a mechanistic framework in which proteinopathies arise from failures of innate immune discrimination at the structural level. Through computational analysis of α-synuclein conformations, I evaluated surface accessibility and hydrophobic patterning to assess whether aggregated species present unique signatures for selective recognition. The results reveal substantial feature overlap, suggesting that misfolded proteins may evade detection rather than solely resist clearance. I therefore introduce a mimicry-based strategy that inverts molecular mimicry, typically a driver of pathological misrecognition to a tool for selective targeting, reframing intervention as a problem of discrimination, not solely delivery.
Awards (2)
- Bronze Medal
- Selected for CWSF 2026
Competition history
- CWSF 2026
Related projects
ISEF · 2017
Ameliorating Alpha-Synuclein Aggregation in Parkinson's Using Optimized Chaperones: An in silico Approach
ISEF · 2026
Computational Analysis of Alpha-Synuclein Protein Misfolding in Parkinson's Disease and Lewy Body Dementia Using AlphaFold-Predicted Structures and RMSD-Based Metrics
ISEF · 2014
Biochemical Analysis of Post Translation Modification to the Parkinson's Disease Protein Alpha-Synuclein
ISEF · 2026
Frankenstein-Synuclein: Rapid, Structure-Informed in silico Generation of de novo Replacement Protein Variants Using Benign Homologs for Parkinson's Disease Prevention
Closest projects by meaning, across every fair and year in the corpus.